TITLE

Still waiting for predictive biomarkers in Barrett's oesophagus

AUTHOR(S)
Moyes, L. H.; Going, J. J.
PUB. DATE
September 2011
SOURCE
Journal of Clinical Pathology;Sep2011, Vol. 64 Issue 9, p742
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Barrett's oesophagus is important as a precursor of oesophageal adenocarcinoma via a metaplasia-dysplasiacarcinoma sequence. It is often detected on upper gastrointestinal endoscopy. In the absence of glandular dysplasia the risk of progression to cancer is low but ascertainment of dysplasia is not always straightforward. Sparse mucosal sampling may miss dysplasia, or reactive changes may be overinterpreted due to inter and intraobserver variation. Low-grade and even highgrade dysplasia do not necessarily progress, provided prevalent cancer has been rigorously excluded. This indeterminacy motivates an ongoing search for clinically useful predictive biomarkers. Although many genetic and epigenetic abnormalities have been associated with neoplastic progression in Barrett's mucosa no molecular tests have as yet been accepted into routine pathology practice. Challenges of assay definition remain and many marker studies lack statistical power or have other methodological flaws. Even where strong evidence of clinically relevant predictive value does exist (in the case of ploidy analysis by flow or image cytometry) adoption has been minimal, likely reflecting technological and possible reimbursement obstacles. Well designed multicentre studies are likely to be required to translate improved knowledge of Barrett's carcinogenesis into clinically significant progress on predictive testing, and will require a degree of cooperation not so far widely seen in the field.
ACCESSION #
65207563

 

Related Articles

  • Safety and efficacy of endoscopic spray cryotherapy for Barrett's dysplasia: results of the National Cryospray Registry. Ghorbani, S.; Tsai, F. C.; Greenwald, B. D.; Jang, S.; Dumot, J. A.; McKinley, M. J.; Shaheen, N. J.; Habr, F.; Coyle, W. J. // Diseases of the Esophagus;Apr2016, Vol. 29 Issue 3, p241 

    Retrospective series have shown the efficacy of endoscopic spray cryotherapy in eradicating high-grade dysplasia ( HGD) in Barrett's esophagus ( BE); however, prospective data are lacking, and efficacy for low-grade dysplasia ( LGD) is unclear. The aim of this study was to assess the efficacy...

  • The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus. di Pietro, Massimiliano; Boerwinkel, David F.; Shariff, Mohammed Kareem; Xinxue Liu; Telakis, Emmanouil; Lao-Sirieix, Pierre; Walker, Elaine; Couch, George; Mills, Leanne; Nuckcheddy-Grant, Tara; Slininger, Susan; O'Donovan, Maria; Visser, Mike; Meijer, Sybren L.; Kaye, Philip V.; Wernisch, Lorenz; Ragunath, Krish; Bergman, Jacques J. G. H. M.; Fitzgerald, Rebecca C. // Gut;Jan2015, Vol. 64 Issue 1, p49 

    Objective Endoscopic surveillance for Barrett's oesophagus (BO) is limited by sampling error and the subjectivity of diagnosing dysplasia. We aimed to compare a biomarker panel on minimal biopsies directed by autofluorescence imaging (AFI) with the standard surveillance protocol to derive an...

  • Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. Peters, F. P.; Curvers, W. L.; Rosmolen, W. D.; de Vries, C. E.; ten Kate, F. J. W.; Krishnadath, K. K.; Fockens, P.; Bergman, J. J. G. H. M. // Diseases of the Esophagus;Sep2008, Vol. 21 Issue 6, p475 

    The study's aim was to retrospectively evaluate the surveillance history of Barrett's esophagus (BE) patients with endoscopically treated early neoplasia. All BE patients endoscopically treated for early cancer (EC) or high-grade intraepithelial neoplasia (HGIN) in a lesion or mass between 1998...

  • Management of Barrett's esophagus with low-grade dysplasia. Harrison, M; Allen, J E; Gorrepati, V S; López-Jamar, J M E; Sharma, P // Diseases of the Esophagus;Apr2018, Vol. 31 Issue 4, pN.PAG 

    SUMMARY: Barrett's esophagus progresses to esophageal adenocarcinoma in a stepwise histological fashion of no dysplasia, low grade dysplasia, high grade dysplasia and cancer. Hence the progression to cancer from various histological stages is different. Progression to cancer from low grade...

  • Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett’s esophagus. Hennig, Ewa E.; Mikula, Michal; Orlowska, Janina; Jarosz, Dorota; Bielasik, Andrzej; Regula, Jaroslaw; Ostrowski, Jerzy // Journal of Molecular Medicine;Feb2008, Vol. 86 Issue 2, p233 

    Barrett’s esophagus represents a well-defined precursor lesion of esophageal adenocarcinoma, although only a subset of patients with these lesions advances to invasive cancer. Currently, reliable markers predicting neoplastic progression in Barrett’s esophagus are lacking. The only...

  • Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Haidry, R. J.; Butt, M. A.; Dunn, J. M.; Gupta, A.; Lipman, G.; Smart, H. L.; Bhandari, P.; Smith, L.; Willert, R.; Fullarton, G.; Di Pietro, M.; Gordon, C.; Penman, I.; Barr, H.; Patel, P.; Kapoor, N.; Hoare, J.; Narayanasamy, R.; Ang, Y.; Veitch, A. // Gut;Aug2015, Vol. 64 Issue 8, p1192 

    Background Barrett's oesophagus (BE) is a premalignant condition leading to oesophageal adenocarcinoma (OAC). Treatment of neoplasia at an early stage is desirable. Combined endoscopic mucosal resection (EMR) followed by radiofrequency ablation (RFA) is an alternative to surgery for patients...

  • Lifetime Alcohol Consumption and Risk of Barrett's Esophagus. Thrift, Aaron P.; Pandeya, Nirmala; Smith, Kylie J.; Mallitt, Kylie-ann; Green, Adèle C; Webb, Penelope M.; Whiteman, David C. // American Journal of Gastroenterology;Jul2011, Vol. 106 Issue 7, p1220 

    OBJECTIVES:Alcohol is a carcinogen that may increase the risk of Barrett's esophagus (BE) through direct contact with esophageal mucosa. However, few studies have investigated this association and findings have been inconsistent. We sought to examine the association between measures of total and...

  • Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus. Bobryshev, Yuri V.; Tran, Dinh; Killingsworth, Murray C.; Buckland, Michael; Lord, Reginald V. N. // Journal of Gastrointestinal Surgery;Mar2009, Vol. 13 Issue 3, p442 

    Background: The development of Barrett's esophagus is poorly understood, but it has been suggested that cardiac mucosa is a precursor of intestinal type metaplasia and that inflammation of cardiac mucosa may play a role in the formation of Barrett's esophagus. The present study was...

  • Aplasia cutis congenita associated with type I split cord malformation: Unusual case. Abuzayed, Bashar; Erdincler, Pamir // Journal of Pediatric Neurosciences;Jan-Apr2014, Vol. 9 Issue 1, p27 

    A full-term newborn girl born with large skin, muscle, bone and dural defect in the lumbo-sacral area. The lesion included a split spinal cord by a perpendicular bony spur and connected from its tip to the upper lamina. Patient was diagnosed with aplasia cutis congenita (ACC) associated with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics